Female
Multidisciplinary Team(s)
Genitourinary Oncology
Department/Research Program(s)
Department of Oncology
Cancer Type(s)
Adrenal Cancer
Bladder cancer
Kidney Cancer
Penile Cancer
Prostate Cancer
Testicular Cancer
Ureter Cancer
Urethra Cancer
Contact Info
Email:
heathe@karmanos.org
来自 http://www.karmanos.org/physicians/Elisabeth-Heath?Disease=229PageIndex=0SortDirection=1
Education
Fellowship
Medical oncology Fellowship: Johns Hopkins School of Medicine and Hospital, Baltimore, MD
Medical School
Jefferson Medical College
Residency
Georgetown University School of Medicine and Hospital, Washington, DC
Graduate Training
Jefferson Medical College
Professional Memberships/Associations
American Society of Clinical Oncology
American Association for Cancer Research
Southwest oncology Group
Board Certifications
Internal Medicine
American Board of Internal Medicine
Clinical Interests
Medical Oncology
Research Interests
Multidisciplinary care of patients with prostate, kidney, bladder, testicular cancer and Phase I clinical trials.
Awards
2011Blue Cross Blue Shield of Michigan Foundation, McDevitt Excellence in Research Award
2011Wayne State University, Physician Golden Heart Faculty Award
Detroit's Top Docs, Hour Magazine
2010NCI Cancer Clinical Investigator Team Leadership Award
2010The Spirit of Detroit Award
Publications
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother Pharmacol. 2011 Oct 22. PMID: 22020315 Authors: Chung V, Heath EI, Schelman WR, Johnson BM, Kirby LC, Lynch KM, Botbyl JD, Lampkin TA, Holen KD.
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. Invest New Drugs. 2011 Aug 3. PMID: 21799472 Authors: Heath EI, Forman K, Malburg L, Gainer S, Suttle AB, Adams L, Ball H, Lorusso P.
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anticancer Drugs. 2011 Sep;22(8):794-800. PMID: 21799472 Authors: Gupta S, Parsa V, Heilbrun LK, Smith DW, Dickow B, Heath E, Vaishampayan
Inhibition of HDAC1 by Maspin Abrogates Epigenetic Silencing of Glutathione S-Transferase Pi (GSTp) in Prostate Carcinoma Cells. Mol Cancer Res. 2011 May 26. PMID: 21622623 Authors: Li X, Kaplun A, Lonardo F, Heath EI, Sakr FH, Irish J, Sakr WA, Sheng S.
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol. 2011 Jan 1;2(1):18-24. PMID: 21503272 Authors: Zafar SF, Heilbrun LK, Vishnu P, Jasti P, Venkatramanamoorthy R, Ding L, Lorusso PM, Heath EI.
